Federal Register / Vol. 79, No. 242 / Wednesday, December 17, 2014 / Notices 75157 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Healthcare Professionals .................. Survey Screening Forms ................. 2,250 1 10/60 375 

General Public .................................. Surveys ............................................ 2,625 1 45/60 1,969 

Healthcare Professionals .................. Surveys ............................................ 1,125 1 45/60 844 

General Public .................................. Pre/Post Tests .................................. 1,750 1 45/60 1,313 

Healthcare Professionals .................. Pre/Post Tests .................................. 750 1 45/60 563 

TOTAL ....................................... ........................................................... 17,500 ........................ ........................ 7,982 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–29503 Filed 12–16–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Office for State, Tribal, Local and 

Territorial Support (OSTLTS) Meeting 

In accordance with Presidential 

Executive Order No. 13175, November 

6, 2000, and the Presidential 

Memorandum of November 5, 2009, and 

September 23, 2004, Consultation and 

Coordination with Indian Tribal 

Governments, CDC/Agency for Toxic 

Substances and Disease Registry 

(ATSDR), announces the following 

meeting and Tribal Consultation 

Session: 

Name: Tribal Advisory Committee (TAC) 

Meeting and 12th Biannual Tribal 

Consultation Session 

Times and Dates: 

8:00 a.m.–5:00 p.m., February 10, 2015 (TAC 

Meeting) 

8:00 a.m.–5:00 p.m., February 11, 2015 (12th 

Biannual Tribal Consultation Session) 

Place: The TAC Meeting and Tribal 

Consultation Session will be held at CDC 

Headquarters, 1600 Clifton Road, NE., Global 

Communications Center, Auditorium B3, 

Atlanta, Georgia 30333. 

Status: The meetings are being hosted by 

CDC/ATSDR in-person only and are open to 

the public. Attendees must pre-register for 

the event by Friday, January 23, 2015, at the 

following link: http://www.cdc.gov/tribal/

meetings.html. 

Purpose: The purpose of these recurring 

meetings is to advance CDC/ATSDR support 

for and collaboration with tribes, and to 

improve the health of tribes through, 

including but not limited to, assisting in 

eliminating the health disparities faced by 

Indian Tribes, ensuring that access to critical 

health and human services and public health 

services is maximized to advance or enhance 

the social, physical, and economic status of 

Indians; and promoting health equity for all 

Indian people and communities. To advance 

these goals, CDC/ATSDR conducts 

government-to-government consultations 

with elected tribal officials or their 

authorized representatives. Consultation is 

an enhanced form of communication that 

emphasizes trust, respect, and shared 

responsibility. It is an open and free 

exchange of information and opinion among 

parties that leads to mutual understanding 

and comprehension. 

Matters for Discussion: The TAC and CDC 

leaders will discuss the following public 

health issue topics: Native specimens, injury 

prevention and occupational safety, hepatitis 

C virus, tuberculosis, and communication 

and engagement with tribes; however, 

discussion is not limited to these topics. 

During the 12th Biannual Tribal 

Consultation Session, tribes and CDC leaders 

will engage in a listening session with CDC’s 

director and roundtable discussions with 

CDC senior leaders, and tribes will have an 

opportunity to present testimony on tribal 

health issues. 

Tribal leaders are encouraged to submit 

written testimony by January 23, 2015, to 

April R. Taylor, Public Health Analyst for the 

Tribal Support Unit, OSTLTS, via mail to 

4770 Buford Highway NE., MS E–70, Atlanta, 

Georgia 30341 or email to TribalSupport@

cdc.gov. 

Depending on the time available, it may be 

necessary to limit the time of each presenter. 

The agenda is subject to change as 

priorities dictate. 

Information about the TAC, CDC’s Tribal 

Consultation Policy, and previous meetings 

can be found at the following web link: 

http://www.cdc.gov/tribal. 

Contact person for more information: April 

R. Taylor, Public Health Analyst, CDC/

OSTLTS, 4770 Buford Highway NE., MS E– 

70, Atlanta, Georgia 30341; email: ARTaylor@

cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–29489 Filed 12–16–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Occupational Safety and 

Health Training Project Grants, PAR10– 

288, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 

6:00 p.m.–8:00 p.m., January 13, 2015 

(Closed) 

8:00 a.m.–8:00 p.m., January 14, 2015 

(Closed) 

Place: Atlanta Airport Marriott, 4711 Best 

Road, Atlanta, Georgia 30337, Telephone: 

(404) 766–7900 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Occupational Safety and Health 

Training Project Grants, PAR10–288, initial 

review.’’ 

Contact Person for More Information: 

Donald Blackman, Ph.D., Scientific Review 

Officer, CDC, 2400 Century Center Parkway, 

NE., 4th Floor, Room 4204, Mailstop E–74, 

Atlanta, Georgia 30345, Telephone: (404) 

498–6185, DYB7@CDC.GOV. 

The Director, Management Analysis and 

Services Office, has been delegated the 

mstockstill on DSK4VPTVN1PROD with NOTICES

75158 Federal Register / Vol. 79, No. 242 / Wednesday, December 17, 2014 / Notices 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–29488 Filed 12–16–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC); Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 11:00 a.m.–1:00 p.m. 

(EST), January 13, 2015. 

Place: This meeting will be held by 

teleconference. 

Status: Open to the public, limited only by 

the availability of telephone ports. The 

public is welcome to participate during the 

public comment period, tentatively 

scheduled from 12:45 p.m. until 12:50 p.m. 

To participate in the teleconference, please 

dial (877) 930–8819 and enter code 1579739. 

Purpose: The Advisory Committee to the 

Director, CDC, shall advise the Secretary, 

HHS, and the Director, CDC, on policy and 

broad strategies that will enable CDC to fulfill 

its mission of protecting health through 

health promotion, prevention, and 

preparedness. The committee recommends 

ways to prioritize CDC’s activities, improve 

results, and address health disparities. It also 

provides guidance to help CDC work more 

effectively with its various private and public 

sector constituents to make health protection 

a practical reality. 

Matters for Discussion: The Advisory 

Committee to the Director will receive 

updates from the State, Tribal, Local and 

Territorial Subcommittee; the External 

Laboratory Safety Workgroup, and the Public 

Health—Health Care Collaboration 

Workgroup; and an update from the CDC 

Director on the Ebola response. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Carmen Villar, MSW, Designated Federal 

Officer, ACD, CDC, 1600 Clifton Road NE., 

M/S D–14, Atlanta, Georgia 30333; 

Telephone (404) 639–7158; Email: 

GHickman@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. 2014–29487 Filed 12–16–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–2033] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Survey on the 

Occurrence of Foodborne Illness Risk 

Factors in Selected Institutional 

Foodservice and Retail Food Stores 

Facility Types 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

a survey entitled ‘‘Survey on the 

Occurrence of Foodborne Illness Risk 

Factors in Selected Institutional 

Foodservice and Retail Food Stores 

Facility Types (2015–2025).’’ 

DATES: Submit either electronic or 

written comments on the collection of 

information by February 17, 2015. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http://

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

Agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes Agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA (44 

U.S.C. 3506(c)(2)(A)) requires Federal 

Agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of FDA’s functions, including whether 

the information will have practical 

utility; (2) the accuracy of FDA’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques, 

when appropriate, and other forms of 

information technology. 

Survey on the Occurrence of Foodborne 

Illness Risk Factors in Selected Retail 

and Foodservice Facility Types (2015– 

2025) (OMB Control Number 0910– 

NEW) 

I. Background 

From 1998–2008, FDA’s National 

Retail Food Team conducted a study to 

measure trends in the occurrence of 

foodborne illness risk factors, 

preparation practices, and employee 

behaviors most commonly reported to 

the Centers for Disease Control and 

Prevention as contributing factors to 

foodborne illness outbreaks at the retail 

level. Specifically, data was collected by 

FDA Specialists in retail and 

foodservice establishments at 5-year 

intervals (1998, 2003, and 2008) in order 

to observe and document trends in the 

occurrence of the following foodborne 

illness risk factors: 

• Food from Unsafe Sources, 

• Poor Personal Hygiene, 

• Inadequate Cooking, 

mstockstill on DSK4VPTVN1PROD with NOTICES